Education only, not medical advice◆21+◆Every dose is an example to finalize with a licensed provider
BioregulatorsKhavinson bioregulator dipeptideNot FDA-approved · research compound
Vilon
Vilon (Khavinson) · Lys-Glu
Evidence: Studied in humans. Example dose: finalize with a provider. Not a fact-check stamp.
67-100 mcg daily – 67-100 mcgSubQ5 consecutive days per 4-week cycle
Immune system modulatorSmallest known bioregulator
Vilon (Lys-Glu) is a Khavinson bioregulator dipeptide (the smallest bioregulator) targeting immune system function. Despite being only two amino acids, it demonstrates bioregulatory activity on immune cell gene expression consistent with Khavinson's theory that even minimal peptide sequences can modulate specific tissue gene programs.
Quick Start
Route
SubQ injection
Start low
67-100 mcg SubQ
Frequency
5 consecutive days per 4-week cycle
Timing
No fasting required
Starting dose. 67-100 mcg — Daily
SubQ injection, any time of day. 10-20 day courses, 2-3 cycles per year with 4-6 months between courses (Khavinson protocol). Pin alone or with other bioregulators only.
❋
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
Tiered Protocols · lowest first
Conservative start
67-100 mcg daily · SubQ injection · 5 consecutive days per 4-week cycle
Often run concurrently with Epithalon for maximum anti-aging epigenetic effects. Human use has been published, but almost entirely by a single research group in Russian-language journals. None of it is registered on any trial registry and most reports were unblinded, so this evidence is far weaker than a controlled trial. Corrected from a class-wide template. The previous milligram figure was copied across unrelated bioregulators; this record's own titration documents the per-compound verified range as 67-100 mcg. The Khavinson citation is animal work and does not validate a human dose.
67-100 mcg
Daily
Reconstitution CalculatorU-100
050100u
Draw to
— units
◆
◆
◆
01
How it works
Vilon modulates immune cell gene expression despite its minimal size. The Lys-Glu sequence appears to interact with specific DNA regulatory regions in immune cells. Mechanism is consistent with Khavinson bioregulatory theory.
02
What to expect
Early
Days 1–7
Days 1-10: Gene changes initiated.
Mid
Weeks 2–4
Weeks 2-8: Gene programs established.
Later
Weeks 4–12
Months: Sustained support.
03
Evidence
HumanPresent
AnimalPresent
In-vitroPresent
Each reference below was re-fetched from its PubMed record, and the quoted sentence was
confirmed to appear in that abstract and to support the claim it sits under. Follow any of
them to read the source.
Exact-molecule evidence boundary: the live abstract reports the quoted finding for Vilon; no broader inference is made.
The review summarizes the results of long-term studies of the authors on the clinical efficacy of peptide bioregulators (Timalin, Thymogen, Vilon, Epithalamin, Prostatilen, Cortexin, Retinalamin) for the prevention of diseases and treatment of people of different age.
Evidence scope. Exact molecule wording appears in the quoted live sentence. Only the population/model, formulation, route, and outcome expressly stated there are supported.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the
same as saying they are false — it marks where the evidence is missing.
Dose/route: 67-100 mcg daily; SubQ injection; 5 consecutive days per 4-week cycle. No selected live abstract sentence verified this complete regimen.
Mechanism as written in source JSON. No selected live abstract sentence verified the complete mechanism at the card formulation/route and relevant population/model.
Primary safety claim as written in source JSON. No selected live abstract sentence verified the complete safety claim for this exact formulation and route.
04
The honest take
◆
Smallest bioregulator
Dipeptide with demonstrated gene expression activity. Supports Khavinson's theory of minimal peptide signaling.
05
Interactions & stacking
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
◆
Pin alone. Vilon must not share a syringe with anything else, whatever the pharmacology says.
PIN ALONE.
Documented together
ThymalinBoth immune-targeting bioregulators.
Keep separate
GHK-CuCopper degrades bioregulators.
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.